share_log

Bruush Oral Care | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yaletown Bros. Ventures Ltd.(30%),Matthew Friesen(30%), etc.

SEC announcement ·  Feb 10 05:38
Summary by Futu AI
On February 5, 2024, Yaletown Bros. Ventures Ltd, along with individuals Matthew Friesen and Bradley Friesen, filed an amendment to Schedule 13D with the United States Securities and Exchange Commission, indicating a significant change in their holdings of Bruush Oral Care Inc. common shares. The group collectively owns approximately 30% of Bruush Oral Care, which includes 33,000,000 common shares issuable upon the exercise of Pre-Funded Warrants. The Friesens, both Canadian citizens, have joint control over Yaletown Bros. Ventures Ltd and are engaged in investment management. From October 11, 2023, to October 24, 2023, their ownership ranged from 63% to 82% of the company's securities. However, recent transactions have seen the Reporting Persons sell a total of 1,776,986 common shares in the open market. The sales took place between February 5 and February 8, 2024, with prices ranging from $0.1051 to $0.1137 per share. The amendment to Schedule 13D includes a Joint Filing Agreement dated February 9, 2024.
On February 5, 2024, Yaletown Bros. Ventures Ltd, along with individuals Matthew Friesen and Bradley Friesen, filed an amendment to Schedule 13D with the United States Securities and Exchange Commission, indicating a significant change in their holdings of Bruush Oral Care Inc. common shares. The group collectively owns approximately 30% of Bruush Oral Care, which includes 33,000,000 common shares issuable upon the exercise of Pre-Funded Warrants. The Friesens, both Canadian citizens, have joint control over Yaletown Bros. Ventures Ltd and are engaged in investment management. From October 11, 2023, to October 24, 2023, their ownership ranged from 63% to 82% of the company's securities. However, recent transactions have seen the Reporting Persons sell a total of 1,776,986 common shares in the open market. The sales took place between February 5 and February 8, 2024, with prices ranging from $0.1051 to $0.1137 per share. The amendment to Schedule 13D includes a Joint Filing Agreement dated February 9, 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.